## Abstract The purpose of this study was to determine whether angiotensin Iβconverting enzyme (ACE) is present in cultured bovine bronchial epithelial cells (BBECs) and whether its activity can be modulated. We found that extracts of confluent monolayers of cultured BBECs degraded [glycineβ1β^14^C
Regulation of angiotensin I-converting enzyme activity in serially cultivated bovine endothelial cells
β Scribed by Eliot M. Rosen; James P. Noveral; Stephen N. Mueller; Elliot M. Levine
- Publisher
- John Wiley and Sons
- Year
- 1985
- Tongue
- English
- Weight
- 865 KB
- Volume
- 122
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Bovine fetal aortic endothelial cells cultured in serum-containing medium accumulate angiotensin I-converting enzyme (ACE) activity and also release it into t h e culture medium. Following subcultivation of a confluent culture using trypsin-EDTA, cellular ACE activity falls 50% within 8 h, but n o A
## Abstract Angiotensinβconverting enzyme (EC 3.4.15.1) is a carboxyterminal dipeptidyl peptidase. The enzyme catalyzes the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II. In addition, the enzyme catabolizes bradykinin. Because of these actions, the enzyme is of pivot
We have demonstrated previously that a variety of agents including corticosteroids, thyroid hormone, cationophores, methylxanthines, and analogues of CAMP-all of which have diversified functions in various tissues-devate cellular angiotensin converting enzyme (ACE) activity of bovine endothelial cel
The purpose of the present study was to contrast a commonly used ACE inhibitor (enalaprilat) with a novel ACE inhibitor (trandolaprilat) in their ability to inhibit 1) pulmonary capillary endothelialbound ACE activity in vivo, 2) arterial pressure responses to i.v. angiotensin I and bradykinin, and